Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lazabemide (Ro 19-6327) is selective, reversible monoamine oxidase B (MAO-B) inhibitor (IC50 values are 0.03 and > 100 μM for MAO-B and MAO-A respectively).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
10 mg | 約6-8 週間 | ¥ 11,500 |
25 mg | 約6-8 週間 | ¥ 25,000 |
50 mg | 約6-8 週間 | ¥ 42,000 |
100 mg | 約6-8 週間 | ¥ 63,000 |
1 mL * 10 mM (in DMSO) | 約6-8 週間 | ¥ 11,000 |
説明 | Lazabemide (Ro 19-6327) is selective, reversible monoamine oxidase B (MAO-B) inhibitor (IC50 values are 0.03 and > 100 μM for MAO-B and MAO-A respectively). |
ターゲット&IC50 | MAO-B:30 nM |
別名 | Ro 19-6327 |
分子量 | 199.64 |
分子式 | C8H10ClN3O |
CAS No. | 103878-84-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 34 mg/mL (170.31 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LAZABEMIDE 103878-84-8 Metabolism Neuroscience Monoamine Oxidase MAO parkinson inhibit radical generation Ro 19-6327 ichemia alzheimer′s smoking cessation Inhibitor DOPAC disease inhibitor